Dr. Chen is interested in pharmacogenomics, medical education, and hospital medicine. He has a particular interest in the medication reconciliation process, prescribing, and quality improvements that decrease costs of care and improve health outcomes. He is also Co-Director of the Personalized Therapeutics Clinic.
Johns Hopkins Hospital
Baltimore
Residency - Internal Medicine
2017
University of Illinois at Chicago
Chicago
MD
2014
University of Illinois at Chicago
Chicago
PharmD
2009
Implementation of pharmacogenomics into inpatient general medicine.
Implementation of pharmacogenomics into inpatient general medicine. Pharmacogenet Genomics. 2023 02 01; 33(2):19-23.
PMID: 36729768
Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients.
Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients. J Pers Med. 2021 Dec 10; 11(12).
PMID: 34945816
Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers. Am J Nephrol. 2021; 52(3):250-260.
PMID: 33827074
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative. Am J Med. 2020 05; 133 Suppl 1:1-27.
PMID: 32362349
Comparing Multiplex PCR and Rapid Urease Test in the Detection of H. pylori in Patients on Proton Pump Inhibitors.
Comparing Multiplex PCR and Rapid Urease Test in the Detection of H. pylori in Patients on Proton Pump Inhibitors. Gastroenterol Res Pract. 2012; 2012:898276.
PMID: 23319944